Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy
出版年份 2021 全文链接
标题
Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy
作者
关键词
-
出版物
EUROPEAN HEART JOURNAL
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2021-06-25
DOI
10.1093/eurheartj/ehab430
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment
- (2020) Nicolas Palaskas et al. Journal of the American Heart Association
- Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology
- (2020) Tienush Rassaf et al. Clinical Research in Cardiology
- Association Between Immune Checkpoint Inhibitors with Cardiovascular Events and Atherosclerotic Plaque
- (2020) Zsofia D. Drobni et al. CIRCULATION
- T cell checkpoint regulators in the heart
- (2019) Nir Grabie et al. CARDIOVASCULAR RESEARCH
- Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy
- (2019) Elisabeth Perez-Ruiz et al. NATURE
- Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis
- (2019) Joe-Elie Salem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Contemporaneous 3D characterization of acute and chronic myocardial I/R injury and response
- (2019) Simon F. Merz et al. Nature Communications
- Autoimmune Myocarditis Caused by Immune Checkpoint Inhibitors Treated With Antithymocyte Globulin
- (2018) Varun Jain et al. JOURNAL OF IMMUNOTHERAPY
- Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis
- (2018) Javid J Moslehi et al. LANCET
- Melanoma
- (2018) Dirk Schadendorf et al. LANCET
- Immune checkpoint inhibitors and cardiovascular toxicity
- (2018) Alexander R Lyon et al. LANCET ONCOLOGY
- Tumor Necrosis Factor-α in Heart Failure: an Updated Review
- (2018) Sarah M. Schumacher et al. Current Cardiology Reports
- Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
- (2017) Jeffrey Weber et al. NEW ENGLAND JOURNAL OF MEDICINE
- TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
- (2017) Florie Bertrand et al. Nature Communications
- Smoldering myocarditis following immune checkpoint blockade
- (2017) Timothy G. Norwood et al. Journal for ImmunoTherapy of Cancer
- A novel physiological role for cardiac myoglobin in lipid metabolism
- (2017) Ulrike B. Hendgen-Cotta et al. Scientific Reports
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN HEART JOURNAL
- Tumor Necrosis Factor Alpha Inhibits L-Type Ca2+Channels in Sensitized Guinea Pig Airway Smooth Muscle through ERK 1/2 Pathway
- (2016) Jorge Reyes-García et al. MEDIATORS OF INFLAMMATION
- Simultaneous Metabolite, Protein, Lipid Extraction (SIMPLEX): A Combinatorial Multimolecular Omics Approach for Systems Biology
- (2016) Cristina Coman et al. MOLECULAR & CELLULAR PROTEOMICS
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnostic approach of myocarditis: strike the golden mean
- (2014) M. R. Hazebroek et al. Netherlands Heart Journal
- PD-1 Protects against Inflammation and Myocyte Damage in T Cell-Mediated Myocarditis
- (2012) M. L. Tarrio et al. JOURNAL OF IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started